Biocompatible Structures and Compositions
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 61/301,864, filed Feb 5, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,202,853 | Porogen Compositions, Methods of Making and Uses In force · Medium confidence | Allergan, Inc. | In force | Medium confidence | ||
| US 9,138,309 | Porous Materials, Methods of Making and Uses In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 9,205,577 | Porogen Compositions, Methods of Making and Uses In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 10,624,997 | Porogen Compositions, Methods of Making and Uses In force · Medium confidence | Allergan, Inc. | In force | Medium confidence | ||
| US 9,138,308 | Mucosal Tissue Adhesion via Textured Surface In force · Medium confidence | Boston Scientific Scimed, Inc. | In force | Medium confidence | ||
| US 9,522,502 | Porous Materials, Methods of Making and Uses In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 9,072,821 | Biocompatible Structures and Compositions In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 8,889,751 | Porous Materials, Methods of Making and Uses In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 8,685,296 | Porogen Compositions, Method of Making and Uses In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| US 8,877,822 | Porogen Compositions, Methods of Making and Uses In force · High confidence | Allergan, Inc. | In force | High confidence | ||
| 12 more patents in this group · Pro | ||||||
10 of 22 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 22, including 1 expired.
11 of these are in force and held by Allergan, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.